BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15170667)

  • 1. Pathways of urothelial cancer progression suggested by Bayesian network analysis of allelotyping data.
    Bulashevska S; Szakacs O; Brors B; Eils R; Kovacs G
    Int J Cancer; 2004 Jul; 110(6):850-6. PubMed ID: 15170667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 mutation and LOH at chromosome 9 in urothelial carcinoma.
    Beothe T; Nagy A; Farkas L; Kovacs G
    Anticancer Res; 2012 Feb; 32(2):523-7. PubMed ID: 22287741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
    Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
    Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of allelotype profiling for urothelial carcinoma.
    Tzai TS; Chen HH; Chan SH; Ho CL; Tsai YS; Cheng HL; Dai YC; Lin JS; Yang WH; Chow NH
    Urology; 2003 Aug; 62(2):378-84. PubMed ID: 12893368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic pathways and new progression markers for prostate cancer suggested by microsatellite allelotyping.
    von Knobloch R; Konrad L; Barth PJ; Brandt H; Wille S; Heidenreich A; Moll R; Hofmann R
    Clin Cancer Res; 2004 Feb; 10(3):1064-73. PubMed ID: 14871986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
    Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
    Chang HJ; Kim SW; Kim YT; Kim WH
    Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
    Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
    Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N; Jaafart H; Isa MN; Abdullah JM
    Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic classification of combined hepatocellular-cholangiocarcinoma.
    Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
    Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of chromosome 9 alterations as an initial step in urothelial carcinogenesis].
    Habuchi T; Kato T; Takahashi T; Ogawa O
    Hinyokika Kiyo; 2000 Oct; 46(10):749-55. PubMed ID: 11215205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
    Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
    Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization.
    Chang MC; Chang YT; Tien YW; Sun CT; Wu MS; Lin JT
    Oncol Rep; 2005 Oct; 14(4):867-72. PubMed ID: 16142344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
    Takahashi T; Habuchi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Yoshida O
    Cancer Res; 1998 Dec; 58(24):5835-41. PubMed ID: 9865743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelotype analysis of childhood acute lymphoblastic leukemia.
    Takeuchi S; Bartram CR; Wada M; Reiter A; Hatta Y; Seriu T; Lee E; Miller CW; Miyoshi I; Koeffler HP
    Cancer Res; 1995 Nov; 55(22):5377-82. PubMed ID: 7585604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution allelotype of microdissected primary nasopharyngeal carcinoma.
    Lo KW; Teo PM; Hui AB; To KF; Tsang YS; Chan SY; Mak KF; Lee JC; Huang DP
    Cancer Res; 2000 Jul; 60(13):3348-53. PubMed ID: 10910036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.